This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Manufacturing Services

Manufacturing Services

PCI Pharma Services provides full manufacturing services for both investigational and commercial products including highly potent molecules requiring specialist handling.

Through the acquisition of Penn Pharma, PCI has significant experience in providing integrated drug development, clinical trial supply and manufacturing services of solid dose potent products to high standards of safety and quality.

Development and Manufacturing of Highly Potent Molecules – A Center of Excellence

The pharamceutical landscape continues to evolve with more and more products in development being deemed potent. As the biological activity and specificity of Active Pharmaceutical Ingredients (API) increases, dosage strengths are decreasing which had led to this increase in more potent molecules. Significant investment in general contained resources resulted in PCI being awarded ISPE Facility of the Year 2014. Additional investment include both contained roller compaction and fully contained Xcelodose® 600S technology, further driving PCI’s market leading position.

Our dedicated team of specialists will be happy to discuss any of our Pharmaceutical Manufacturing Services with you. Contact us on +1 815-484-1528 (US) or +44 1495 713 633 (UK) or email sales@pciservices.com


PCI: Apprenticeship Awards Program – Supporting and Sustaining Future Talent

Apprentices with PCI Pharma Services have scooped plaudits in the recent ‘Aspire Blaenau Gwent Shared Apprenticeship Programme Awards 2017’ in... View Article

PCI Announces Appointment of Jennifer Goldberg

PCI Pharma Services is pleased to announce the appointment of Jennifer Goldberg to our Manufacturing Business Development team. Jennifer joins... View Article

x